Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A. Gebo, David Sullivan, Jessica E. Ruff et al.|mBio|2023Cited by 22
Early Treatment, Inflammation and Post-COVID ConditionsKelly A. Gebo, David Sullivan, Sonya L. Heath et al.|medRxiv|2023Cited by 5
Erratum for Gebo et al., “Early antibody treatment, inflammation, and risk of post-COVID conditions”Kelly A. Gebo, David Sullivan, Sonya L. Heath et al.|mBio|2023Cited by 5
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody TherapyYuriko Fukuta, David Sullivan, Arturo Casadevall et al.|Open Forum Infectious Diseases|2023Cited by 0